Friday, February 9, 2018

The enzyme that frustrates your weight loss efforts


You've been attempting to eat smaller portions and cut down on some foods entirely, but you're still not losing as much weight as you'd like. Well, a new study says that the complex action of one enzyme may be at the core of the problem.


Why do you struggle to lose weight, even when you think you're doing everything right?
Why do our bodies sometimes appear to turn against us, even as we do our best to stay in shape?
While we may adhere to a better diet and stop indulging in unhealthful foods, some of us will find it difficult to lose the excess weight that troubles us.
The reason behind why our bodies store fatty tissue in the first place is quite straightforward and even intuitive, given the nature of human evolution, explains Dr. Alan Saltiel, from the University of California, San Diego School of Medicine in La Jolla.
We derive energy by burning fat tissue, but sometimes, our bodies deem it necessary to curtail how much fat we burn so that we have enough "fuel" in store for later, when we may have more urgent need of it.
"Human bodies are very efficient at storing energy by repressing energy expenditure to conserve it for later when you need it," Dr. Saltiel notes, adding, "This is nature's way of ensuring that you survive if a famine comes."
Some of the mechanisms at play in this "fuel" storage and energy consumption system are unclear, however — particularly those related to the accumulation of excess fat that leads to obesity. The question is, what pushes the "on/off" button of fat metabolism, and when?
Dr. Saltiel and his team recently directed their attention toward the enzyme TANK-binding kinase 1 (TBK1), which they identified as key when it comes to the body's process of "deciding" how much fat to burn and how much to keep in store, especially over a period of fasting.
"There are two important observations that we have linked to slowing metabolism in obesity and fasting," explains Dr. Saltiel.
"We've discovered two new feedback loops that are intertwined to self-regulate the system. Think of it like your home thermostat, which senses change in temperature to turn heat off and on."
Dr. Alan Saltiel
The researchers' findings were reported today in the journal Cell.

Vicious metabolic cycles

Dr. Saltiel and team worked on the mouse model — using both obese and normal-weight animals — in order to study the role of TBK1 in metabolic processes. They noticed that the enzyme was implicated in two distinct processes, leading to the same result each time.
The first process is kick-started by obesity-related chronic stress, and it leads to inflammation as it activates a pro-inflammatory signaling pathway called NFKB.
NFKB enhances the expression of genes that "dictate" the production of enzymes thought to play a role in both inflammation and the accumulation of body fat, including the gene that encodes TBK1.
TBK1 then disactivates another enzyme, AMPK, which is largely responsible for regulating how much fat we convert into raw energy. This means that, instead of being burned, fat is able to accumulate and lead to excess weight.
The TBK1 enzyme is also implicated in the mechanism that is triggered by fasting. In fasting, the body's energy levels go down. The enzyme AMPK perceives that, and to boost energy, it sends signals to fat cells to convert into energy.

"This feedback loop blocks energy expenditure both through inflammation and fasting," Dr. Saltiel explains. When the scientists noticed this mechanism, they looked for a way to modify it.However, when AMPK is activated, it also boosts the expression of the TBK1 gene, which, once again, leads to the TBK1 enzyme inhibiting the activity of AMPK. A vicious cycle thus ensues, preventing the body from burning the accumulated fat.
"Energy expenditure was restored when we deleted TBK1 from fat cells [in] mice," he continues. "But something else occurred that surprised us — there was an increase in inflammation."

How can we 'restore energy balance?'

A second process with TBK1 at its core leads to an equally vicious cycle. The team also noted that, even as the NFKB pathway triggers the production of TBK1, the enzyme ends up inhibiting the NFKB pathway.
TBK1 normally helps to reduce inflammation without extinguishing it, however. Instead, it keeps it at low levels — when TBK1 is inactivated, the inflammatory response is heightened without regulatory action of the enzyme.
When Dr. Saltiel and colleagues deleted the TBK1 gene in obese mice, this triggered weight loss as well as increased inflammation. To the contrary, when TBK1 was deleted in normal-weight mice, no metabolic change was observed, suggesting that cutting down on calories could also help to reduce inflammation.
"Inhibiting TBK1 has the potential to restore energy balance in states of obesity by enhancing the ability to burn some fat," explains Dr. Saltiel.
While he notes that "[t]his is probably not the only pathway accounting for energy expenditure in fasting or obesity," he adds, "[T]his information provides new insight into how we might develop drugs that inhibit TBK1 or other enzymes involved in metabolism."
Still, the researchers note that taking special drugs won't be enough for those who want to be fitter.
"I think you'll probably still have to do both: reduce energy intake through diet and increase energy expenditure by blocking this compensatory reduction in burning calories," stresses Dr. Saltiel.

Cognitive training helps regain a younger-working brain

Relentless cognitive decline as we age is worrisome, and it is widely thought to be an unavoidable negative aspect of normal aging. Researchers at the Center for BrainHealth at The University of Texas at Dallas, however, say their research could provide new hope for extending our brain function as we age.
In a randomized clinical study involving adults age 56 to 71 that recently published in Neurobiology of Aging, researchers found that after cognitive training, participants' brains were more energy efficient, meaning their brain did not have to work as hard to perform a task.
Dr. Michael Motes, senior research scientist at the Center for BrainHealth and one of the lead authors of the study, said, "Finding a nonpharmacological intervention that can help the aging brain to perform like a younger brain is a welcome finding that potentially advances understanding of ways to enhance brain health and longevity. It is thrilling for me as a cognitive neuroscientist, who has previously studied age-related cognitive decline, to find that cognitive training has the potential to strengthen the aging brain to function more like a younger brain."
To investigate changes in brain efficiency, the research team studied neural activity while the participant performed a task. For the study, 57 cognitively normal older adults were randomly assigned to a cognitive training group, a wait-listed control group, or physical exercise control group. The cognitive training utilized the Strategic Memory Advanced Reasoning Training (SMART) program developed at the Center for BrainHealth.
Cognitive training strategies included how to focus on the most relevant information and filter out the less relevant; ways to continually synthesize information encountered in daily life to encourage deeper thinking; and how to inspire innovative thinking through generating diverse interpretations, solutions and perspectives. Because aerobic exercise has been shown to lead to improvements in processing speed and functional changes within the frontal and other brain regions, it was included as one of the study groups.
The cognitive training was conducted over the course of 12 weeks. Participants in the active control physical exercise program exceeded physical activity guidelines of 150 minutes per week for the 12 weeks.
Using functional magnetic resonance imaging (fMRI), an imaging technique that measures brain activity, researchers examined all three groups at the beginning (baseline), middle, and end of the study while participants performed computer-based speed tasks in the scanner.
The fMRI results provided evidence that cognitive training improved speed-related neural activity. While all groups showed faster reaction times across sessions, the cognitive training group showed a significant increase in the association between reaction time and frontal lobe activity. After training, faster reaction times were associated with lower frontal lobe activity, which is consistent with the more energy-efficient neural activity found in younger adults.
In contrast to the cognitive training group, the wait-listed and physical exercise groups showed significant decreases across sessions in the association between reaction time and frontal lobe activation.
"This discovery of neural efficiency profiles found in the SMART-trained older adults is promising," said Dr. Sandra Bond Chapman, one of the lead authors, Center for BrainHealth founder and chief director. "If replicated, this work paves the way for larger clinical trials to test the ability to harness the potential of the aging mind and its ability to excel -- by working like a younger brain with all the rich knowledge and expertise accrued over time. To counteract the pattern of age-related losses and even enhance the brain's inner workings by 'thinking' in smarter ways is an achievable and highly desirable goal."
Story Source:
Materials provided by Center for BrainHealthNote: Content may be edited for style and length.

Journal Reference:
  1. Michael A. Motes, Uma S. Yezhuvath, Sina Aslan, Jeffrey S. Spence, Bart Rypma, Sandra B. Chapman. Higher-order cognitive training effects on processing speed–related neural activity: a randomized trialNeurobiology of Aging, 2018; 62: 72 DOI: 10.1016/j.neurobiolaging.2017.10.003

Diet may influence the spread of a deadly type of breast cancer, study finds

A single protein building block commonly found in food may hold a key to preventing the spread of an often-deadly type of breast cancer, according to a new multicenter study published today in the medical journal Nature.
Investigators found that by limiting an amino acid called asparagine in laboratory mice with triple-negative breast cancer, they could dramatically reduce the ability of the cancer to travel to distant sites in the body. Among other techniques, the team used dietary restrictions to limit asparagine.
Foods rich in asparagine include dairy, whey, beef, poultry, eggs, fish, seafood, asparagus, potatoes, legumes, nuts, seeds, soy and whole grains. Foods low in asparagine include most fruits and vegetables.
"Our study adds to a growing body of evidence that suggests diet can influence the course of the disease," said Simon Knott, PhD, associate director of the Center for Bioinformatics and Functional Genomics at Cedars-Sinai and one of two first authors of the study. The research was conducted at more than a dozen institutions.
If further research confirms the findings in human cells, limiting the amount of asparagine cancer patients ingest could be a potential strategy to augment existing therapies and to prevent the spread of breast cancer, Knott added.
The researchers studied triple-negative breast cancer cells, which grow and spread faster than most other types of cancer cells. It is called triple negative because it lacks receptors for the hormones estrogen and progesterone and makes little of a protein called HER2. As a result, it resists common treatments -- which target these factors and has a higher-than-average mortality rate.
Research from past studies found that most tumor cells remain in the primary breast site, but a subset of cells leaves the breast and enters the bloodstream. Those cells colonize in the lungs, brain and liver, where they proliferate. The study team wanted to understand the particular traits of the tumor cells circulating in the blood and in the sites where the cancer has spread.
The researchers discovered that the appearance of asparagine synthetase -- the enzyme cells used to make asparagine -- in a primary tumor was strongly associated with later cancer spread.
The researchers also found that metastasis was greatly limited by reducing asparagine synthetase, treatment with the chemotherapy drug L-asparaginase, or dietary restriction. When the lab mice were given food rich in asparagine, the cancer cells spread more rapidly.
"The study results are extremely suggestive that changes in diet might impact both how an individual responds to primary therapy and their chances of lethal disease spreading later in life," said the study's senior author, Gregory J. Hannon, PhD, professor of Cancer Molecular Biology and director, Cancer Research UK Cambridge Institute, University of Cambridge in England.
Investigators now are considering conducting an early-phase clinical trial in which healthy participants would consume a low-asparagine diet. If the diet results in decreased levels of asparagine, the next scientific step would involve a clinical trial with cancer patients. That trial likely would employ dietary restrictions as well as chemotherapy and immunotherapy, Knott said.
Studying the effects of asparagine also could alter treatments for other types of cancer, investigators say.
"This study may have implications not only for breast cancer, but for many metastatic cancers," said Ravi Thadhani, MD, MPH, vice dean, Research and Graduate Research Education, at Cedars-Sinai.
Research reported in this publication was supported in part by the National Cancer Institute of the National Institutes of Health, under these awards numbers: P50-CA58223-09A1, R00 CA194077 and 5P30CA045508; by the National Institutes of Health grant number 5 P01 CA013106-44; and by the Susan G. Komen Foundation (SAC110006); the ICR and CRUK grand challenge award (C59824/A25044); and a grant from the DOD BCRP (W81XWH-1-0300).
Story Source:
Materials provided by Cedars-Sinai Medical CenterNote: Content may be edited for style and length.

Journal Reference:
  1. Simon R. V. Knott, Elvin Wagenblast, Showkhin Khan, Sun Y. Kim, Mar Soto, Michel Wagner, Marc-Olivier Turgeon, Lisa Fish, Nicolas Erard, Annika L. Gable, Ashley R. Maceli, Steffen Dickopf, Evangelia K. Papachristou, Clive S. D’Santos, Lisa A. Carey, John E. Wilkinson, J. Chuck Harrell, Charles M. Perou, Hani Goodarzi, George Poulogiannis, Gregory J. Hannon. Asparagine bioavailability governs metastasis in a model of breast cancerNature, 2018; DOI: 10.1038/nature25465

Ball games and circuit strength training boost bone health in schoolchildren

The type of exercise that children get in school does make a difference. This is shown by a major Danish study from researchers at the University of Southern Denmark and University of Copenhagen. Eight to ten-year-old schoolchildren develop stronger bones, increased muscular strength and improved balance when ball games or circuit training are on the timetable.
The study, which was published in the February 2018 issue of the recognised British Journal of Sports Medicine, examined bone and muscle health in 295 schoolchildren from Frederikssund and Copenhagen over a whole school year where the children participated in the 'FIT FIRST' training concept, looking into the effects of various types of intense interval training at school.
This programme was initiated at University of Copenhagen by researchers Professor Peter Krustrup and Assistant Professor Malte Nejst Larsen, now at the University of Southern Denmark, and run in collaboration between sports coaches and schoolteachers.
In the study, the researchers compared the effects on children who took the normal school PE classes with children who had intense exercise on the timetable for two hours a week in the form of ball games on small pitches or 'circuit training' consisting of gymnastic and strength exercises using their own body weight.
Strong bones in children prevent osteoporosis later in life
"Our research shows that intense exercise at school has clear positive effects on bone density, muscular strength and balance in 8-10-year-old children," says the project leader Peter Krustrup, Professor of Sport and Health Sciences at the University of Southern Denmark.
"In the children in third grade who played ball games three against three or participated in circuit training for 3 x 40 minutes a week, muscular strength increased by 10% and balance improved by 15%, while the children's bone density increased by a whole 45% compared to the control group. These types of sports are great ways for children to "put bone in the bank."
Malte Nejst Larsen, Assistant Professor at the University of Southern Denmark, adds: "The study shows that bone density in the ball-game group rose by 7% in the legs and by 3% in the body as a whole, giving a real boost to bone health. Exercise in school for children aged 8-10 which improves bone density, muscular strength and balance is the first big step towards preventing osteoporosis later in life," he says.
About the FIT FIRST concept
FIT FIRST stands for 'Frequent Intense Training -- Football, Interval Running and Strength Training'.
The concept has been developed based on many years of Danish research into the importance of intensity for effects on cardiovascular and bone health, and the influence of the organisation of sports activities, such as the use of small-sided football, team handball, floorball and basketball on small pitches. Like the concept 'FIFA 11 for Health in Europe', the aim of FIT FIRST is to produce well-specified, evidence-based and implementable tools to boost fitness and health through exercise at school.
The project was run in a partnership between the Copenhagen Centre for Team Sport and Health at the University of Copenhagen, Gentofte Hospital and the municipality of Frederikssund, with financial support from the Nordea Foundation (Nordea-fonden), the Aase and Ejnar Danielsen Foundation, Augustinus Fonden, FIFA's research unit F-MARC, the Danish Football Association (DBU), Team Denmark, the Sports Confederation of Denmark (DIF) and the Danish Ministry of Culture.
Findings from the project
The study of the FIT FIRST concept showed that:
  • Bone density in the legs and in the body as a whole rose by 44% and 46% more in the ball-game group than in the control group, while bone density in the circuit training group rose by 39% and 17% more than in the control group. The increase in bone density in the legs was significantly greater in the ball-game group than in the circuit training group.
  • Bone density in the legs increased by 7.0% in the ball-game group, 5.6% in the circuit training group and 4.0% in the control group, while bone density in the whole body rose by 3.0%, 2.9% and 2.1% in the three groups.
  • Muscular strength, measured by a standing long jump (squat jump), increased by 10% for both the ball-game and circuit training groups, while there was no change in the control group.
  • Balance improved by 13% in the ball-game group and by 19% in the circuit training group, while there was no change in the control group.
Story Source:
Materials provided by University of Southern Denmark Faculty of Health SciencesNote: Content may be edited for style and length.

Journal Reference:
  1. Malte Nejst Larsen, Claus Malta Nielsen, Eva Wulff Helge, Mads Madsen, Vibeke Manniche, Lone Hansen, Peter Riis Hansen, Jens Bangsbo, Peter Krustrup. Positive effects on bone mineralisation and muscular fitness after 10 months of intense school-based physical training for children aged 8–10 years: the FIT FIRST randomised controlled trialBritish Journal of Sports Medicine, 2018; 52 (4): 254 DOI: 10.1136/bjsports-2016-096219

Gut bacteria can be good, and bad, for health

The human microbiome -- the trillions of tiny bacteria that live in and on our bodies -- is emerging as an increasingly important player in health and wellness. But, our co-existence with these organisms is complex, and scientists are learning that even minor changes in this relationship can lead to big problems with our health.
In a new study published in the journal Cell Host & Microbe, researchers from the University of Rochester Medical Center found that impairing a rare group of cells in the small intestine allows gut bacteria to invade the organ and cause major inflammation. The study was conducted in mice, but has implications for the treatment of inflammatory bowel disease (IBD), a group of disorders characterized by chronic inflammation in the digestive track.
Keeping our guts happy and healthy
Keeping our guts in good shape requires the cooperation of multiple intestinal cells with the bacteria that live around them. Though small in number, intestinal cells called Paneth cells play an important role; they make antimicrobial compounds that keep bacteria in check and help form the lining of the small intestine, a physical barrier between the organ and the resident bacteria.
Previous research shows that changes or mutations in Paneth cells are associated with increased inflammation, including in individuals with Crohn's disease, a type of IBD. But, scientists were unsure how Paneth cells opened the door to inflammatory damage.
Bad things happen when the guards are gone
Researchers led by Felix O. Yarovinsky, M.D. found the answer in a process called autophagy, which helps cells remove unwanted cellular material or debris. His team turned off autophagy in Paneth cells in mice and then exposed them to a stressor -- a parasite called Toxoplasma gondii. Without autophagy, the barrier between the small intestine and the gut bacteria broke down; bacteria invaded the organ and caused severe infection and inflammation.
"Paneth cells are like the guardians of the intestine and autophagy is like their armor," said Yarovinsky, associate professor in the Center for Vaccine Biology and Immunology and the Department of Microbiology and Immunology at URMC. "When we removed their armor, the Paneth cells couldn't control the intestinal bacteria and it went wild, causing severe disease."
The study suggests that normal autophagy in Paneth cells is required to regulate bacteria in the gut, keeping it at bay and preventing the gut bacteria from invading host tissue. Paneth cells make up just 2 percent of the cells in the intestine, and the fact that restricting autophagy in these cells led to big problems was an unexpected result.
Gut bacteria play a role in inflammatory bowel disease
Scientists know that gut bacteria play a role in the development of IBD, which includes Crohn's disease and ulcerative colitis. But how bacteria in the gut are controlled in these conditions remains elusive. This study and others point to Paneth cells as key regulators of the interactions between host and gut bacteria, and further research could inform the design of future therapies.
This work was supported by grants from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and the Burroughs Wellcome Foundation. Elise Burger, Alessandra Araujo and Américo López-Yglesias from URMC contributed to the research, along with scientists from University of Michigan and University of Texas Southwestern Medical Center.
Story Source:
Materials provided by University of Rochester Medical CenterNote: Content may be edited for style and length.

Journal Reference:
  1. Elise Burger, Alessandra Araujo, Américo López-Yglesias, Michael W. Rajala, Linda Geng, Beth Levine, Lora V. Hooper, Ezra Burstein, Felix Yarovinsky. Loss of Paneth Cell Autophagy Causes Acute Susceptibility to Toxoplasma gondii-Mediated InflammationCell Host & Microbe, 2018; DOI: 10.1016/j.chom.2018.01.001

Enzyme plays a key role in calories burned both during obesity and dieting

Ever wonder why obese bodies burn less calories or why dieting often leads to a plateau in weight loss? In both cases the body is trying to defend its weight by regulating energy expenditure. Until now, how this happens has been a mystery.
"Human bodies are very efficient at storing energy by repressing energy expenditure to conserve it for later when you need it," said Alan Saltiel, PhD, director of the UC San Diego Institute for Diabetes and Metabolic Health. "This is nature's way of ensuring that you survive if a famine comes."
In a paper publishing in Cell on February 8, University of California San Diego School of Medicine researchers identify the enzyme TANK-binding kinase 1 (TBK1) as a key player in the control of energy expenditure -- or calories burned -- during both obesity and fasting.
"There are two important observations that we have linked to slowing metabolism in obesity and fasting," said Saltiel. "We've discovered two new feedback loops that are intertwined to self-regulate the system. Think of it like your home thermostat, which senses change in temperature to turn heat off and on."
Using mouse models, researchers observed the first loop: Chronic stress triggered by obesity causes inflammation through the activation of the pathway NFKB. This pathway induces genes associated with inflammation and obesity including TBK1. When TBK1 is activated, it shuts down AMPK, one of the master regulators of energy expenditure, thus reducing a cell's ability to burn calories, and resulting in fat storage. This is the mechanism by which obesity reduces energy expenditure.
As it turns out, the enzyme AMPK also senses changes in energy levels during fasting and increases expenditure by instructing cells -- especially adipocytes (fat cells) -- to burn fat as an energy source. But, when fasting activates AMPK it initiates TBK1, which ultimately inhibits AMPK's role in burning fat.
"This feedback loop blocks energy expenditure both through inflammation and fasting," said Saltiel. "Energy expenditure was restored when we deleted TBK1 from fat cells mice. But, something else occurred that surprised us -- there was an increase in inflammation."
TBK1 is involved in a second feedback loop: While NKFB induces TBK1, TBK1 turns around and inhibits NFKB. The activation of TBK1 normally reduces inflammation, without completely eliminating it, causing it to be low grade. Without TBK1, inflammation increases.
Deletion of TBK1 in obese mice resulted in weight loss and increased inflammation, but in normal weight mice there was no change. This also explains how restricting calories might reduce inflammation.
"Inhibiting TBK1 has the potential to restore energy balance in states of obesity by enhancing the ability to burn some fat," said Saltiel. "This is probably not the only pathway accounting for energy expenditure in fasting or obesity, but this information provides new insight into how we might develop drugs that inhibit TBK1 or other enzymes involved in metabolism."
One possible TBK1 inhibitor is called amlexanox, an anti-inflammatory and anti-allergic drug used to treat asthma that was developed in the 1980s in Japan. In a paper published in Cell Metabolism last year, Saltiel and team reported a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled clinical trial of a subset of patients with type 2 diabetes who used amlexanox for 12 weeks.
In a previous study, Saltiel and colleagues reported that when TBK1 is induced in obese mice it caused a drop in energy expenditure or reduction in calories burned. Giving obese mice amlexanox caused them to lose weight, while their sensitivity to insulin increased, improving their diabetes and fatty liver disease.
The current paper reveals why amlexanox may have been effective.
"It may be that if we tweak this pathway we will rev up the metabolism again to improve energy expenditure," said Saltiel. "I think you'll probably still have to do both: reduce energy intake through diet and increase energy expenditure by blocking this compensatory reduction in burning calories. We know that diets alone don't work and this is why."
Co-authors include: Kai in Wong, Xiaoli Sun, Zhongji Liao, UC San Diego; Peng Zhao, Shannon M. Reilly, UC San Diego and University of Michigan; and Maeran Uhm, University of Michigan.
Story Source:
Materials provided by University of California - San Diego. Original written by Yadira Galindo. Note: Content may be edited for style and length.

Journal References:
  1. Peng Zhao, Kai in Wong, Xiaoli Sun, Shannon M. Reilly, Maeran Uhm, Zhongji Liao, Yuliya Skorobogatko, Alan R. Saltiel. TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose TissueCell, 2018; 172 (4): 731 DOI: 10.1016/j.cell.2018.01.007
  2. Elif A. Oral, Shannon M. Reilly, Andrew V. Gomez, Rasimcan Meral, Laura Butz, Nevin Ajluni, Thomas L. Chenevert, Evgenia Korytnaya, Adam H. Neidert, Rita Hench, Diana Rus, Jeffrey F. Horowitz, BreAnne Poirier, Peng Zhao, Kim Lehmann, Mohit Jain, Ruth Yu, Christopher Liddle, Maryam Ahmadian, Michael Downes, Ronald M. Evans, Alan R. Saltiel. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 DiabetesCell Metabolism, 2017; 26 (1): 157 DOI: 10.1016/j.cmet.2017.06.006